Medopharm is one of the leading pharmaceutical companies in India developing, manufacturing, and marketing affordable medicines in India and abroad. Over the past five decades, we have manufactured affordable medicines that have made a profound impact on the life of patients worldwide.

As a global pharmaceutical company, we are committed to comply with the highest standards in pharmaceutical manufacturing. At Medopharm, we value life and we would like to be valued by our global partners for our vision and ethics in all our business activities.

Business Overview:

Founded in 1970 by our Visionary Late ShriMohanmulji Chordia, Medopharm is operated by a team of highly committed professionals. The company started in Chennai, Tamil Nadu, India, with a single manufacturing unit formulating only 2 products, Chloramphenicol, and tetracycline capsules. Today, Medopharm has captured the pharmaceutical market on a global scale with 300+ product range in over 100 countries.

With a systematically organized contract manufacturing process that addresses the manufacture of high-quality products, we have captured the niche market segment in a time span of 5 decades. A dedicated team that focuses on key international markets has leveraged our expertise in the manufacture of APIs and formulations to market various products successfully across the globe.

Our manufacturing facilities are approved by various regulatory agencies such as WHO-GMP-Government of India, PMPB–MALAWI, PPB-KENYA, MoH–SRI LANKA, MoH–CONGO, NDA–UGANDA, TFDA-TANZANIA, MCAZ-ZIMBABWE, DRU–BOTSWANA. PSF–TAJIKISTAN, REPUBLIC OF IVORY COAST, NAFDAC–Nigeria, MISSION PHARMA– Denmark, UNICEF–Denmark, Médecins Sans Frontières (MSF)–France, AMSTEL FARMA, IDA, MEG, & IMRES–Netherlands, TROGE–Germany, PFSCM–USA, PAN AMERICA HEALTH ORGANISATION (PAHO), NDSO-LESOTHO, and ZAMBIA.

Our Core Competencies:

• World-Class Quality products
• Expertise in Regulatory affairs
• Operational excellence and efficiency
• Value System
• Patient-focused affordable medicine
• Best shipping lines with minimum transits